Indication
Patient
9 clinical trials
14 products
Product
SitagliptinClinical trial
A Phase 1, Open-Label, Sequential, Multiple-Dose, Drug-Drug Interaction Study of Dorzagliatin and Sitagliptin in Subjects With Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2019-08-30
Product
DorzagliatinClinical trial
Comparison of the Sedative Effects of Dexmedetomidine and Propofol During Peribulbar Anaesthesia in Patients Undergoing Vitrectomy Surgery: A Prospective Randomized Clinical TrialStatus: Recruiting, Estimated PCD: 2025-05-01
Product
DexmedetomidineProduct
PropofolClinical trial
A Randomised Controlled Trial of a 12-dose Rifapentine and Isoniazid (RPT+INH) Regimen Using Direct Observed Therapy (DOT) Versus 6 Months of Daily Isoniazid for Latent Tuberculosis Infection (LTBI) in Socially Marginalised PeopleStatus: Terminated, Estimated PCD: 2023-02-09
Product
RifapentineProduct
IsoniazidClinical trial
To Explore the Effects of Naldebain Combined With Thoracic Paravertebral Block in Video-assisted Thoracoscopic Surgery.Status: Recruiting, Estimated PCD: 2024-05-07
Product
Nalbuphine SebacateClinical trial
Open-label, Randomized Comparative Study to Assess Biosimilar Pegfilgrastim Versus Biosimilar Filgrastim in Patients With Multiple Myeloma and Lymphoma Post Autologous Hematopoietic Stem Cell TransplantationStatus: Not yet recruiting, Estimated PCD: 2024-11-01
Product
Grastofil®Product
LapelgaClinical trial
Lidocaine Spray vs Viscous Lidocaine Solution Plus Lidocaine Spray in Patients Undergoing Non-Sedated Esophagogastroduodenoscopy: A Randomized Controlled TrialStatus: , Estimated PCD: 2024-07-04
Product
LidocaineClinical trial
Evaluating the Efficacy, Compliance, and Patient Satisfaction of a New Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital PopulationStatus: Recruiting, Estimated PCD: 2024-06-01
Product
Dropless RegimenProduct
Standard RegimenClinical trial
Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement: A Pilot StudyStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Product
BupivacaineClinical trial
ACCELERATE a Multisite Prospective Hybrid (Effectiveness-implementation) Type 2 Design, Single-arm, Mixed-methods Study of a Simplified Accelerated ART Initiation Protocol for People With HIV Who Are Out of Care.Status: Recruiting, Estimated PCD: 2025-05-01